Prevention of Hepatitis B reactivation in the setting of immunosuppression
Venessa Pattullo
Clin Mol Hepatol. 2016;22(2):219-237.   Published online 2016 Jun 13     DOI: https://doi.org/10.3350/cmh.2016.0024
Citations to this article as recorded by Crossref logo
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantatio:a multi-institutional experience from an HBV endemic area
Yibo Wu, Yi Chen, Panpan Zhu, Baodong Ye, Ying Lu, Jimin Shi, Yamin Tan, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Jianping Lan, Ting Si, Lihong Ni, He Huang, Yi Luo
Annals of Hematology.2022;[Epub]     CrossRef
Antivirale Medikamente
Jakob J. Malin, Till Bunse, Christoph D. Spinner, Ulrike Protzer
Der Internist.2022;[Epub]     CrossRef
Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy
Hsien-Chung Yu, Jui-Cheng Tseng, Ling-Ying Lu, Jwi-Chieh Hu, Yan-Hua Chen, Chiao-Lin Hsu, Pin-Chieh Wu, Guang-Yuan Mar, Kung-Hung Lin
European Journal of Gastroenterology & Hepatology.2021; 33(1): 107.     CrossRef
Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation
Yibo Wu, He Huang, Yi Luo
Frontiers in Immunology.2021;[Epub]     CrossRef
HBV Reactivation in Patients with HBsAg(-)/HBcAb(+) Induced by Rituximab Combined with Chemotherapy: A Case Report and Literature Review
碧碧 宣
Advances in Clinical Medicine.2021; 11(11): 5224.     CrossRef
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patricia E. Carreira, Noé Brito García, Petra Díaz del Campo Fontecha, José María Pego Reigosa, José A. Gómez Puerta, Rafaela Ortega-Castro, Beatriz Tejera Segura, José María Aguado García, Julián Torre-Cisneros,
Reumatología Clínica (English Edition).2021;[Epub]     CrossRef
Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patricia E. Carreira, Noé Brito García, Petra Díaz del Campo Fontecha, José María Pego Reigosa, José A. Gómez Puerta, Rafaela Ortega-Castro, Beatriz Tejera Segura, José María Aguado García, Julián Torre-Cisneros,
Reumatología Clínica.2021;[Epub]     CrossRef
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu
Frontiers in Oncology.2021;[Epub]     CrossRef
Management of immunosuppressants in the era of coronavirus disease-2019
Michael Manansala, Robert Baughman, Richard Novak, Marc Judson, Nadera Sweiss
Current Opinion in Pulmonary Medicine.2021; 27(3): 176.     CrossRef
Management of Hepatitis-B Virus Infection in Immunocompromised Children: A Single Center Experience
Pier Luigi Calvo, Michele Pinon, Dominic Dell’Olio, Andrea Carpino, Eleonora Biasin, Antonio Pizzol, Silvia Catalano, Licia Peruzzi, Caterina Rigazio, Fabio Cisarò, Anna Opramolla, Sebastian Dorin Asaftei, Paola Quarello, Franca Fagioli
Journal of Pediatric Gastroenterology & Nutrition.2021; 72(4): 597.     CrossRef
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
Sun Yoo, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Changhoon Yoo, Baek-Yeol Ryoo, Jonggi Choi
Clinical Gastroenterology and Hepatology.2021;[Epub]     CrossRef
The compliance of our practice of hepatitis B virus screening with the current guidelines in patients undergoing chemotherapy for hematological malignancies
Funda PEPEDİL TANRİKULU, Didar YANARDAĞ AÇIK, Bilal AYGUN, Mehmet BANKİR, Mikail ÖZDEMİR
Journal of Surgery and Medicine.2021; 5(11): 1095.     CrossRef
Use of Hepatitis B Virus–Positive Organs in Organ Transplantation
Saro Khemichian, Jeffrey Kahn, Norah A. Terrault
Clinics in Liver Disease.2021; 25(4): 841.     CrossRef
Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
Branko Borojevic, Ayushi Chauhan, Scott Patterson
BMJ Case Reports.2021; 14(7): e243526.     CrossRef
Effect of Low-Dose Corticosteroid Use on HBV Reactivation in HBsAg-positive Rheumatoid Arthritis Patients
Wooseong Jeong, Jung-Yoon Choe, Byung-Cheol Song, Chang-Keun Lee, Hoon-Suk Cha, Byeongzu Ghang, Jinseok Kim
The Open Rheumatology Journal.2021; 15(1): 39.     CrossRef
Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
Ping Li, Lili Zhou, Shiguang Ye, Wenjun Zhang, Junbang Wang, Xiaochen Tang, Jie Liu, Yangyang Xu, Wenbin Qian, Aibin Liang
Frontiers in Immunology.2021;[Epub]     CrossRef
The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia
Hiroshi Okano, Tatsunori Nakano, Ryugo Ito, Ami Tanaka, Yuji Hoshi, Keiji Matsubayashi, Hiroki Asakawa, Kenji Nose, Satomi Tsuruga, Tomomasa Tochio, Hiroaki Kumazawa, Yoshiaki Isono, Hiroki Tanaka, Shimpei Matsusaki, Tomohiro Sase, Tomonori Saito, Katsumi
Clinical Journal of Gastroenterology.2020; 13(2): 252.     CrossRef
Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Aibin Zhang, Yibo Wu, Yamin Tan, Jimin Shi, Yanmin Zhao, Yongxian Hu, Jian Yu, Weiyan Zheng, Xiaoyu Lai, Mingming Zhang, Yuanyuan Zhu, Yishan Ye, Yaping Huang, Shan Fu, He Huang, Yi Luo
Biology of Blood and Marrow Transplantation.2020; 26(5): 956.     CrossRef
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen
Intestinal Research.2020; 18(1): 18.     CrossRef
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B
Giordano Madeddu, Vito Fiore, Michela Melis, Silvia Ortu, Franca Mannu, Alberto Augusto Muredda, Giovanni Garrucciu, Franco Bandiera, Salvatore Zaru, Paola Bagella, Diego Francesco Calvisi, Sergio Babudieri
Scientific Reports.2020;[Epub]     CrossRef
Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen‐negative, core antibody‐positive recipients
Jihye Kim, Se Jin Chung, Dong Hyun Sinn, Kyo Won Lee, Jae Berm Park, Wooseong Huh, Jung Eun Lee, Hye Ryoun Jang, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2020; 27(7): 739.     CrossRef
Alteración de las pruebas de función hepática en el paciente inmunodeprimido
N. Marcos Carrasco, A. Martínez Ortega, D. Burgos Santamaría, L. Téllez Villajos
Medicine - Programa de Formación Médica Continuada Acreditado.2020; 13(5): 282.     CrossRef
Management of hepatitis B in the era of checkpoint inhibition
Janice Dutcher
Journal for ImmunoTherapy of Cancer.2020; 8(1): e000276.     CrossRef
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad, Albert J. Czaja
Hepatology.2020; 72(2): 671.     CrossRef
Adherence to guidelines across different specialties to prevent infections in patients undergoing immunosuppressive therapies
David R. Chadwick, Laila Sayeed, Matthew Rose, Emily Budd, Mo Mohammed, Sarah Harrison, Jaskiran Azad, Jamie Maddox
BMC Infectious Diseases.2020;[Epub]     CrossRef
Safety considerations with biologics and new inflammatory bowel disease therapies
Natália S.F. Queiroz, Miguel Regueiro
Current Opinion in Gastroenterology.2020; 36(4): 257.     CrossRef
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle
Clinical Microbiology Reviews.2020;[Epub]     CrossRef
Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update
Michele S. Barnhill, Joshua M. Steinberg, Joseph J. Jennings, James H. Lewis
Current Gastroenterology Reports.2020;[Epub]     CrossRef
Biological features of hepatitis B virus strains associated with fulminant hepatitis
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic
Future Virology.2020; 15(7): 455.     CrossRef
Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016
Graça M. Dores, Rochelle E. Curtis, Nicole H. Dalal, Martha S. Linet, Lindsay M. Morton
Journal of Clinical Oncology.2020; 38(35): 4149.     CrossRef
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
Dimitrios C Ziogas, Frosso Kostantinou, Evangelos Cholongitas, Amalia Anastasopoulou, Panagiotis Diamantopoulos, John Haanen, Helen Gogas
Journal for ImmunoTherapy of Cancer.2020; 8(2): e000943.     CrossRef
Hepatitis B virus reactivation following imatinib therapy: A comparative review of 9 cases
Faisal Inayat, Fei Song, Nouman Safdar Ali, Muhammad Haseeb Aslam, Aishatu Aloma, Hilal Hachem, Muhammad Wasif Saif
Journal of Oncology Pharmacy Practice.2019; 25(6): 1500.     CrossRef
Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report
Arturo Ciccullo, F. R. Ponziani, E. Maiolo, F. Pallavicini, M. Pompili
Infection.2019; 47(2): 313.     CrossRef
HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
Linda Drößler, Clara Lehmann, Karin Töpelt, Dirk Nierhoff, Jörg J. Vehreschild, Jan Rybniker, Michael Hallek, Julia Fischer, Verena Stormberg, Gerd Fätkenheuer, Ulrike Wieland, Norma Jung
Infection.2019; 47(2): 293.     CrossRef
Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease
Uday N. Shivaji, Caroline L. Sharratt, Tom Thomas, Samuel C. L. Smith, Marietta Iacucci, Gordon W. Moran, Subrata Ghosh, Neeraj Bhala
Alimentary Pharmacology & Therapeutics.2019; 49(6): 664.     CrossRef
Infection par le virus de l’hépatite B : histoire naturelle, manifestations cliniques et principes thérapeutiques
O. Paccoud, L. Surgers, K. Lacombe
La Revue de Médecine Interne.2019; 40(9): 590.     CrossRef
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
Hae Lim Lee, Jeong Won Jang, Ji Won Han, Sung Won Lee, Si Hyun Bae, Jong Young Choi, Nam Ik Han, Seung Kew Yoon, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Chang-Ki Min, Dong-Wook Kim, Jong Wook Lee
Digestive Diseases and Sciences.2019; 64(10): 2992.     CrossRef
A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
Romina Salpini, Arianna Battisti, Luna Colagrossi, Domenico Di Carlo, Lavinia Fabeni, Lorenzo Piermatteo, Carlotta Cerva, Miriam Lichtner, Claudio Mastroianni, Massimo Marignani, Sarah Maylin, Constance Delaugerre, Filomena Morisco, Nicola Coppola, Aldo M
Journal of Viral Hepatitis.2019; 26(7): 846.     CrossRef
Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola
World Journal of Gastroenterology.2019; 25(26): 3299.     CrossRef
Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic
Viruses.2019; 11(9): 778.     CrossRef
The epidemiology of hepatitis B virus infection in Korea
Sun Young Yim, Ji Hoon Kim
The Korean Journal of Internal Medicine.2019; 34(5): 945.     CrossRef
Rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive therapy
Bilal Toka, Ahmet Tarik Eminler, Emel Gönüllü, Mukaddes Tozlu, Mustafa Ihsan Uslan, Erkan Parlak, Oğuz Karabay, Aydin Seref Koksal
Rheumatology International.2019; 39(12): 2077.     CrossRef
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
Alessandra Zannella, Massimo Marignani, Paola Begini
Viruses.2019; 11(9): 858.     CrossRef
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies
Danielle J. Smalls, Reagan E. Kiger, LeAnn B. Norris, Charles L. Bennett, Bryan L. Love
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2019; 39(12): 1190.     CrossRef
Profilaktyka reaktywacji zakażeń HBV – rekomendacje grupy roboczej profilaktyki reaktywacji HBV
Małgorzata Pawłowska, Robert Flisiak, Lidia Gil, Andrzej Horban, Iwona Hus, Jerzy Jaroszewicz, Ewa Lech-Marańda, Jan Styczyński
Acta Haematologica Polonica.2019; 50(4): 192.     CrossRef
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Anil Arora, Shivaram P. Singh, Ashish Kumar, Vivek A. Saraswat, Rakesh Aggarwal, Manisha Bangar, Pradip Bhaumik, Harshad Devarbhavi, Radha K. Dhiman, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Dharmesh Kapoor, Kaushal Madan, Jimmy Narayan, Sandeep Nij
Journal of Clinical and Experimental Hepatology.2018; 8(1): 58.     CrossRef
Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis
Charat Thongprayoon, Wisit Kaewput, Konika Sharma, Karn Wijarnpreecha, Napat Leeaphorn, Patompong Ungprasert, Ankit Sakhuja, Franco H Cabeza Rivera, Wisit Cheungpasitporn
World Journal of Hepatology.2018; 10(2): 337.     CrossRef
Viral Hepatitis and Acute Liver Failure
Daniel Sedhom, Melroy D’Souza, Elizabeth John, Vinod Rustgi
Clinics in Liver Disease.2018; 22(2): 289.     CrossRef
Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
Matthew Kelling, Lubomir Sokol, Samir Dalia
Cancer Control.2018; 25(1): 107327481876787.     CrossRef
Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis
Jiang Su, Li Long, Kun Zou
Clinical Rheumatology.2018; 37(12): 3201.     CrossRef
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nag
Journal of Clinical and Experimental Hepatology.2018; 8(4): 403.     CrossRef
Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
Vincenzo Malagnino, Djeneba Bocar Fofana, Karine Lacombe, Joel Gozlan
Open Forum Infectious Diseases.2018;[Epub]     CrossRef
Disparities in Hepatitis B Virus Infection and Immunity Among New York City Asian American Patients, 1997 to 2017
Amy S. Tang, Janice Lyu, Su Wang, Qingqing He, Perry Pong, Aaron M. Harris
American Journal of Public Health.2018; 108(S4): S327.     CrossRef
The Positivity Ratios of HBsAg, Anti-HBs and Isolated Anti-HBc in Patients with Breast and Gynecologic Cancers Prior to Chemotherapy
Ayşe İnci, Özgür Açıkgöz, Mustafa Uygar Kalaycı, Volkan Ülker
Journal of Clinical and Experimental Investigations.2018;[Epub]     CrossRef
Minimal Risk of HBV Reactivation in Resolved HBV-Infected Patients During Immunosuppressive Therapy
Yüksel Gümürdülü, Salih Tokmak, Ümit Karaoğullarından, Didem Arslan Taş, İ. Oğuz Kara, Ahmet Barış Güzel, Ghanim Khatib
SSRN Electronic Journal .2018;[Epub]     CrossRef
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke
Journal of Hepatology.2017; 67(2): 370.     CrossRef
Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea
Kyeong Hun Lee, Kyu Seok Shim, In Seok Lim, Soo Ahn Chae, Sin Weon Yun, Na Mi Lee, Young Bae Choi, Dae Yong Yi
BMC Pediatrics.2017;[Epub]     CrossRef
Hepatitis B in renal transplant patients
Smaragdi Marinaki, Kyriaki Kolovou, Stratigoula Sakellariou, John N Boletis, Ioanna K Delladetsima
World Journal of Hepatology.2017; 9(25): 1054.     CrossRef
Hepatitis B in patients with hematological diseases: An update
Chiara Coluccio, Paola Begini, Alfredo Marzano, Adriano Pellicelli, Barbara Imperatrice, Giulia Anania, Gianfranco Delle Fave, Massimo Marignani
World Journal of Hepatology.2017; 9(25): 1043.     CrossRef